We are live on !
Find out more
TC
TFS Capital Portfolio holdings
AUM
$255M
Turnover
65.26%
1-Year Est. Return
32.31%
This Fund
S&P 500
This Quarter Est. Return
+4.78%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$255M
AUM Growth
-$53M
(-17%)
Cap. Flow
-$59.9M
Cap. Flow % of AUM
Cap. Flow %
-23.49%
Top 10 Holdings %
Top 10 Hldgs %
4.95%
Holding
921
New
282
Increased
115
Reduced
203
Closed
319
Avg Time Held
0.4
years
Top 10 Avg Time Held
0.1
years
Top 20 Avg Time Held
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MYR Group
MYRG
|
+$1.17M |
| 2 |
Intrawest Resorts Holdings, Inc.
SNOW
|
+$1.14M |
| 3 |
Fossil Group
FOSL
|
+$1.13M |
| 4 |
RTEC
Rudolph Technologies Inc
RTEC
|
+$1.04M |
| 5 |
Penske Automotive Group
PAG
|
+$1.03M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ePlus
PLUS
|
+$1.71M |
| 2 |
TOWR
Tower International, Inc.
TOWR
|
+$1.54M |
| 3 |
Heidrick & Struggles
HSII
|
+$1.49M |
| 4 |
SpartanNash
SPTN
|
+$1.4M |
| 5 |
Insight Enterprises
NSIT
|
+$1.31M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.14% |
| 2 | Industrials | 16.14% |
| 3 | Consumer Discretionary | 14.21% |
| 4 | Technology | 13.68% |
| 5 | Financials | 8.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
EBSB
176
DELISTED
Meridian Bancorp, Inc.
EBSB
| $477K | 0.19% |
+28,235
| New | +$487K |
2017 Q2
0 quarters
|
|
177
Ralph Lauren
RL
$22.8B
| $470K | 0.18% |
6,375
+495
| +8% | +$37.1K |
2017 Q1
1 quarter
|
|
178
Invesco
IVZ
$12.7B
| $469K | 0.18% |
+13,331
| New | +$435K |
2017 Q2
0 quarters
|
|
179
Revvity
RVTY
$17.2B
| $467K | 0.18% |
6,860
-1,403
| -17% | -$87.2K |
2017 Q1
1 quarter
|
|
|
MYOK
180
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $467K | 0.18% |
35,615
-35,444
| -50% | -$467K |
2017 Q1
1 quarter
|
|
181
Amgen
AMGN
$252B
| $466K | 0.18% |
2,704
-207
| -7% | -$33.7K |
2016 Q2
4 quarters
|
|
182
Valero Energy
VLO
$106B
| $466K | 0.18% |
6,915
-310
| -4% | -$20.1K |
2017 Q1
1 quarter
|
|
183
Biogen
BIIB
$37.5B
| $464K | 0.18% |
1,711
-78
| -4% | -$20.6K |
2016 Q4
2 quarters
|
|
184
Brunswick
BC
$4.89B
| $463K | 0.18% |
7,378
-443
| -6% | -$25.8K |
2016 Q3
3 quarters
|
|
185
Gilead Sciences
GILD
$208B
| $463K | 0.18% |
6,539
-252
| -4% | -$16.8K |
2016 Q3
3 quarters
|
|
186
Aramark
ARMK
$14.2B
| $462K | 0.18% |
15,606
-2,242
| -13% | -$61.4K |
2016 Q2
4 quarters
|
|
187
ManpowerGroup
MAN
$2.17B
| $462K | 0.18% |
4,139
-508
| -11% | -$52.5K |
2017 Q1
1 quarter
|
|
188
SITE Centers
SITC
$34.5M
| $461K | 0.18% |
+39,487
| New | +$515K |
2017 Q2
0 quarters
|
|
|
CELG
189
DELISTED
Celgene Corp
CELG
| $459K | 0.18% |
3,531
-317
| -8% | -$38.8K |
2016 Q3
3 quarters
|
|
|
MDRX
190
DELISTED
Veradigm Inc. Common Stock
MDRX
| $458K | 0.18% |
35,890
-11,202
| -24% | -$136K |
2017 Q1
1 quarter
|
|
191
Centene
CNC
$35.3B
| $456K | 0.18% |
11,406
-1,858
| -14% | -$70.1K |
2017 Q1
1 quarter
|
|
192
Hasbro
HAS
$16.9B
| $455K | 0.18% |
+4,076
| New | +$420K |
2017 Q2
0 quarters
|
|
193
Hanover Insurance
THG
$8.53B
| $455K | 0.18% |
+5,133
| New | +$441K |
2017 Q2
0 quarters
|
|
194
Bankunited
BKU
$3.12B
| $454K | 0.18% |
+13,460
| New | +$465K |
2017 Q2
0 quarters
|
|
195
Humana
HUM
$54B
| $453K | 0.18% |
+1,884
| New | +$427K |
2017 Q2
0 quarters
|
|
196
United Therapeutics
UTHR
$25.2B
| $453K | 0.18% |
+3,489
| New | +$435K |
2017 Q2
0 quarters
|
|
197
Graham Holdings Company
GHC
$5.19B
| $452K | 0.18% |
753
-94
| -11% | -$56.3K |
2016 Q1
5 quarters
|
|
198
NRG Energy
NRG
$20.4B
| $452K | 0.18% |
+26,222
| New | +$440K |
2017 Q2
0 quarters
|
|
199
Regeneron Pharmaceuticals
REGN
$98.8B
| $452K | 0.18% |
920
-319
| -26% | -$140K |
2017 Q1
1 quarter
|
|
|
PKY
200
DELISTED
Parkway, Inc.
PKY
| $452K | 0.18% |
+19,742
| New | +$398K |
2017 Q2
0 quarters
|
|
Similar funds
KC
FRM
WFG
RP
BJCM
TFS Capital's Q2 2017 Portfolio in Review
As of Q2 2017, TFS Capital held 921 positions worth $255M, down 17% from $308M the previous quarter. Its ten largest holdings account for 4.9% of the portfolio.
TFS Capital withdrew a net $59.9M in Q2 2017, closing 319 positions and reducing 203 holdings. Its most notable exit was ePlus, an estimated $1.71M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, TFS Capital opened a new position in MYR Group worth $1.06M.
- TFS Capital's largest Q2 2017 buy was MYR Group: 34,070 shares worth $1.06M.
- TFS Capital added most to ModivCare in Q2 2017, an estimated $871K increase.
- TFS Capital's biggest Q2 2017 reduction was Insight Enterprises, cutting an estimated $1.31M.
- TFS Capital fully exited ePlus in Q2 2017, selling an estimated $1.71M.
- TFS Capital's ten largest holdings make up 4.9% of its $255M portfolio in Q2 2017.
- TFS Capital opened 282 new positions and closed 319 in Q2 2017.
- TFS Capital's portfolio value fell 17% quarter-over-quarter to $255M.
Based on TFS Capital's 13F filing for Q2 2017, filed 11 Aug 2017.